Forbindelser som NS3-serinproteaseinhibitorer for hepatitt C-virus, farmasøytiske preparater og anvendelse av forbindelsene til fremstilling av et medikament

摘要

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.